Literature DB >> 26479978

Haploidentical hematopoietic stem cell transplantation for nonresponders to immunosuppressive therapy against acquired severe aplastic anemia.

L Liu1,2, X Wang1, S Jin1, L Hao3, Y Zhang2, X Zhang2, D Wu1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26479978     DOI： 10.1038/bmt.2015.249

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

Review 1.  Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects.

Authors:  Rupert Handgretinger; Thomas Klingebiel; Peter Lang; Paul Gordon; Dietrich Niethammer
Journal:  Pediatr Transplant       Date:  2003

Review 2.  How I treat acquired aplastic anemia.

Authors:  Phillip Scheinberg; Neal S Young
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

Review 3.  Guidelines for the diagnosis and management of aplastic anaemia.

Authors:  Judith C W Marsh; Sarah E Ball; Jamie Cavenagh; Phil Darbyshire; Inderjeet Dokal; Edward C Gordon-Smith; Jane Keidan; Andrew Laurie; Anna Martin; Jane Mercieca; Sally B Killick; Rhona Stewart; John A L Yin
Journal:  Br J Haematol       Date:  2009-08-10       Impact factor: 6.998

Review 4.  Aplastic anemia: therapeutic updates in immunosuppression and transplantation.

Authors:  Phillip Scheinberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 5.  Allogeneic BM transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities.

Authors:  Gérard Socié
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

6.  A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia.

Authors:  L P Xu; K Y Liu; D H Liu; W Han; H Chen; Y H Chen; X H Zhang; Y Wang; F R Wang; J Z Wang; X J Huang
Journal:  Bone Marrow Transplant       Date:  2012-05-28       Impact factor: 5.483

7.  CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.

Authors:  C H Tzeng; P M Chen; S Fan; J H Liu; T J Chiou; R K Hsieh
Journal:  Bone Marrow Transplant       Date:  1996-08       Impact factor: 5.483

8.  Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.

Authors:  Dao-Pei Lu; Lujia Dong; Tong Wu; Xiao-Jun Huang; Mei-Jie Zhang; Wei Han; Huan Chen; Dai-Hong Liu; Zhi-Yong Gao; Yu-Hong Chen; Lan-Ping Xu; Yao-Chen Zhang; Han-Yun Ren; Dan Li; Kai-Yan Liu
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

9.  Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.

Authors:  C A Keever; T N Small; N Flomenberg; G Heller; K Pekle; P Black; A Pecora; A Gillio; N A Kernan; R J O'Reilly
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

10.  First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.

Authors:  Frank Peinemann; Ulrich Grouven; Nicolaus Kröger; Carmen Bartel; Max H Pittler; Stefan Lange
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240
View more
  5 in total

Review 1.  Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents.

Authors:  Ho Joon Im; Kyung-Nam Koh; Jong Jin Seo
Journal:  Blood Res       Date:  2016-03-25

2.  Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?-a systematic review and meta-analysis.

Authors:  Ruonan Li; Jingke Tu; Jingyu Zhao; Hong Pan; Liwei Fang; Jun Shi
Journal:  Stem Cell Res Ther       Date:  2021-02-04       Impact factor: 6.832

3.  Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Limin Liu; Xin Zhao; Miao Miao; Yanming Zhang; Wenjing Jiao; Meiqing Lei; Huifen Zhou; Qingyuan Wang; Yifeng Cai; Liyun Zhao; Xiaohui Shangguan; Zefa Liu; Jinge Xu; Fengkui Zhang; Depei Wu
Journal:  Front Oncol       Date:  2021-09-21       Impact factor: 6.244

4.  Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter study.

Authors:  Limin Liu; Miao Miao; Hailong He; Shunqing Wang; Yanming Zhang; Ailian Guo; Wenjing Jiao; Meiqing Lei; Yifeng Cai; Xiaohui Shangguan; Zefa Liu; Jinge Xu; Xiaoli Li; Liansheng Zhang; Depei Wu
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

5.  Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China.

Authors:  Yunjing Zeng; Sanbin Wang; Jishi Wang; Li Liu; Yi Su; Zhixiang Lu; Xuemei Zhang; Yanqi Zhang; Jiang Fan Zhong; Lihui Peng; Qiang Liu; Yinghao Lu; Lei Gao; Xi Zhang
Journal:  Sci Rep       Date:  2018-02-06       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.